May 2, 2012
Glytec is the first company to achieve this medical device certification in the glycemic management product space.
Glytec, LLC, a privately held medical software company, announced that it has achieved the ISO 13485:2003 Certification for its quality management and assurance processes for the safe design, production and installation of Glucommander 2.0 Enterprise software.
September 19, 2011
Glytec will use the capital primarily to expand its direct US sales force, increase its international presence and advance research and development.
GlucoTec, Inc., the privately-held parent company of Glytec, LLC, today announced that it has completed a Series A Preferred Stock financing totaling $8,273,078.
May 11, 2011
Glytec, a world leader in glycemic management solutions, has announced that it has achieved the U.S. Department of Commerce Safe Harbor Certification.
The Safe Harbor provides a legal framework allowing for protection of personal data generated from European countries and the safe transfer of data to the U.S. By certifying to the Safe Harbor, Glytec had demonstrated compliance with the Safe Harbor privacy principles accepted by all 27 member states of the European Union.
March 7, 2011
The Glucommander Plus software provides healthcare professionals with individualized insulin dosing requirements for hospitalized patients.
Dave Roberts, MD, Vice President and Chief Medical Officer at West Tennessee Healthcare recently conducted a webinar presenting a systems approach to inpatient glucose control using the Glucommander Plus software from Glytec. The software includes many safety guardrails including predictive warning and alerts, a fully-integrated and real-time reporting engine, and precision bolus dosing of meal-time insulin.
November 1, 2010
The G+ Enterprise Edition software is now compatible with select Android, BlackBerry, and iPhone devices, including the new iPhone 4 and iPad.
Glytec, LLC, a leader in glycemic management solutions, announced today that it has released a new enhancement to its inpatient blood glucose management software. The G+ Enterprise Edition software provides both intravenous and subcutaneous dosing recommendations of insulin and glucose and can be accessed from any computer within a hospital’s network. Users with mobile devices can now access real-time patient information, allowing for better monitoring of insulin dosing and blood glucose levels.
July 20, 2010
Glytec announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its G+ System Enterprise Edition, the next generation of the industry standard sophisticated insulin management software system.
The system incorporates new innovative features including certain algorithm enhancements, additional predictive warning and alerts, a fully-integrated and real-time reporting engine, and precision bolus dosing of meal-time insulin. The Enterprise Edition software provides both intravenous and subcutaneous dosing recommendations of insulin and glucose and can be accessed from any computer within a hospital’s network.
June 28, 2010
The Glucommander computerized intravenous insulin controller (CIIC) for insulin dosing enables providers to avoid hypoglycemia by accurately controlling patients’ blood glucose to desired target levels.
What if your facility could safely and effectively achieve tight glycemic control among patients in the intensive care unit (ICU) with little danger of severe hypoglycemia? According to study results presented at the American Diabetes Association 70th Scientific Sessions, this outcome is possible through the use of Glucommander, a computerized algorithm that accurately manages intravenous insulin.
